PROF Stock Analysis: Buy, Sell, or Hold?
PROF - Profound Medical Corp. Common Stock
$7.50
0.02 (0.27%)
▲
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 05, 2026
30d
Get Alerted When PROF Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PROF shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: PROF shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: PROF is currently trading at $7.50, which is considered slightly low relative to its 30-day fair value range of $7.47 to $8.24.
Technical Outlook: Technically, PROF is in a strong uptrend. Immediate support is located at $7.22, while resistance sits at $8.60.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $12.35 (+64.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PROF is in a strong uptrend. Immediate support is located at $7.22, while resistance sits at $8.60.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $12.35 (+64.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$7.47 -
$8.24
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 64.7% below Wall St target ($12.35)
- CAUTION: Recommendation downgraded due to -5.8% 5-day decline
Fair Price Analysis
30-Day Fair Range
$7.47 -
$8.24
Current vs Fair Value
SLIGHTLY LOW
Expected Move (7 Days)
±$0.67
(8.9%)
Support & Resistance Levels
Support Level
$7.22
Resistance Level
$8.60
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-7.44
Wall Street Target
$12.35
(+64.7%)
Revenue Growth (YoY)
86.8%
Profit Margin
-275.2%
Last updated: February 01, 2026 7:51 PM ET
Data refreshes hourly during market hours. Next update: 8:51 PM
Data refreshes hourly during market hours. Next update: 8:51 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PROF showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 65 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$134 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 63 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$370 | 54 HOLD |
